Cargando…

PB2451: EVALUATION OF PLATELET PARAMETERS IN PATIENTS WITH SECONDARY FAILURE OF PLATELET RECOVERY AND CYTOMEGALOVIRUS INFECTION AFTER HEMATOPOIETIC STEM CELL TRANSPLANTATION

Detalles Bibliográficos
Autores principales:	Cao, Yigeng, Pang, Aiming, Jiang, Erlie
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2023
Materias:	Publication Only
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10429178/ http://dx.doi.org/10.1097/01.HS9.0000976508.44122.af

Ejemplares similares

Evaluation of Platelet Parameters in Patients With Secondary Failure of Platelet Recovery and Cytomegalovirus Infection After Hematopoietic Stem Cell Transplantation
por: Zhao, Yujian, et al.
Publicado: (2023)

PB2452: PREVALENCE AND SEVERITY OF COVID-19 IN ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION PATIENTS IN CHINA
por: Gao, Hongye, et al.
Publicado: (2023)

PB1848: IN VITRO CHEMOSENSITIVITY ASSAY PREDICTS TREATMENT RESPONSE IN RELAPSED AND REFRACTORY ACUTE MYELOID LEUKEMIA
por: Cao, Yigeng, et al.
Publicado: (2023)

PB2425: EFFICACY AND SAFETY OF COMBINED THERAPY OF RECOMBINANT HUMAN THROMBOPOIETIN AND ELTROMBOPAG FOR TREATMENT OF PERSISTENT THROMBOCYTOPENIA AFTER HEMATOPOIETIC STEM CELL TRANSPLANTATION
por: Pan, Pan, et al.
Publicado: (2023)

PB2596: OPTIMIZING PLATELET TRANSFUSION FOR CLINICAL PRACTICE. DO PLATELETS AGE MATTER FOR THERAPEUTIC PLATELETS TRANSFUSION?
por: Attallah, Samy, et al.
Publicado: (2023)

PB2635: FEATURES OF PLATELET PATHOLOGY IN PREGNANT WOMEN
por: Zaynutdinova, Dilafruz, et al.
Publicado: (2023)

PB2639: CHANGES IN PLATELETS IN CHRONIC LIVER DISEASES
por: Nuriddinova, Nodira
Publicado: (2023)

Efficacy of Recombinant Human Thrombopoietin for the Treatment of Secondary Failure of Platelet Recovery After Allogeneic HSCT
por: Cao, Yigeng, et al.
Publicado: (2022)

PB2690: CURRENT STATUS AND FACTORS INFLUENCING FEAR OF COVID-19 IN HEMATOPOIETIC STEM CELL TRANSPLANTATION PATIENTS: A CROSS-SECTIONAL STUDY
por: Peng, Fucong, et al.
Publicado: (2023)

PB2199: A REAL WORLD STUDY OF PEG-RHG-CSF ON HEMATOPOIETIC RECOVERY AFTER ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION
por: Xu, J., et al.
Publicado: (2022)

PB2448: RESTORATION OF HEMOGRAM PARAMETERS IN PATIENTS WITH HEMOBLASTOSIS AFTER TRANSPLANTATION OF AUTOLOGOUS HEMATOPOIETIC STEM CELLS
por: Natalia, Isaeva, et al.
Publicado: (2023)

PB2614: MISDIAGNOSIS OF PRIMARY IMMUNE THROMBOCYTOPENIA IN THE COMMUNITY SETTING AND ITS ASSOCIATION WITH INHERITED PLATELET DISORDERS: REPORTING NEW VARIANTS OF INHERITED PLATELET DISORDERS
por: Lara-Martinez, Hugo, et al.
Publicado: (2023)

PB1731: INOTUZUMAB OZOGAMICIN IN LYMPHOID B-CELL MALIGNANCY：A SINGLE CENTER ANALYSIS IN THE REAL WORLD
por: LV, Mengnan, et al.
Publicado: (2023)

PB2617: ACTIVATED PLATELETS: A POTENTIAL EXTRA SOURCE OF ANTIANGIOGENIC FACTORS IN PREECLAMPSIA
por: Dionisio, Laura Mattana, et al.
Publicado: (2023)

PB2298: THE RELATIONSHIP BETWEEN PLATELET SPECIFIC ANTIBODIES AND THE SEVERITY OF NEWLY DIAGNOSED PEDIATRIC ITP
por: Dong, S.
Publicado: (2022)

PB2176: MRNA OF MPL AND JAK2 GENES IN PLATELETS IS ASSOCIATED WITH THEIR ASPIRIN RESISTANCE IN MPN PATIENTS
por: Stolyar, Marina, et al.
Publicado: (2023)

PB2585: IS THROMBOCYTOPENIA WITH INCREASED IMMATURE PLATELET FRACTION [IPF] IN ICU PATIENTS,A BAD PROGNOSIS?
por: Lourenco, Enna Maria, et al.
Publicado: (2023)

PB2624: CLINICAL WHOLE EXOM SEQUENCING FOR CONGENITAL PLATELET DISORDERS: ONE SINGLE CENTER EXPERIENCE
por: Piñeiro, Victor Portela, et al.
Publicado: (2023)

PB2589: EFFICACY AND SAFETY OF ABCD IN THE TREATMENT OF INVASIVE ASPERGILLOSIS IN PATIENTS WITH HEMATOLOGIC DISEASES
por: Pang, Aiming, et al.
Publicado: (2023)

PB2181: DOES SARCOPENIA INFLUENCE THE SUCCESS OF HEMATOPOIETIC STEM CELL TRANSPLANTATION?
por: Erdogan Yucel, E., et al.
Publicado: (2022)

PB2310: VALUE OF PLATELET SURFACE GP IIB-IIIA AND BLEEDING QUESTIONNAIRE IN IDENTIFICATION OF EGYPTIAN PATIENTS WITH GLANZMANN’S THROMBASTHENIA
por: Saleh, L., et al.
Publicado: (2022)

PB2297: THE PREDICTIVE VALUE OF PLATELET SPECIFIC ANTIBODIES FOR THE FIRST-LINE TREATMENT EFFECT IN NEWLY DIAGNOSED PEDIATRIC ITP
por: Dong, S.
Publicado: (2022)

PB2490: NEUTROPHIL TO LYMPHOCYTE RATIO AND PLATELET TO LYMPHOCYTE RATIO IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS: A MONOCENTRIC STUDY
por: Tounsi, Haifa, et al.
Publicado: (2023)

PB2296: THE PROGNOSTIC ROLE OF NEUTROPHIL TO LYMPHOCYTE RATIO AND PLATELET TO LYMPHOCYTE RATIO IN COVID-19 PATIENTS: A MONOCENTRIC STUDY
por: Boufrikha, W., et al.
Publicado: (2022)

PB2615: HOW WILL COVID-19 RELATED SYMPTOMS AND PLATELET COUNTS CHANGE IN ITP PATIENTS AFTER COVID-19 INFECTION?
por: Chen, Xiaoli, et al.
Publicado: (2023)

PB2460: THE RATE OF NEUTROPHIL RECOVERY IS HELPFUL IN PREDICTING ACUTE GRAFT-VERSUS-HOST DISEASE AFTER ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION: AN OBSERVATIONAL COHORT STUDY
por: Lai, Sihan, et al.
Publicado: (2023)

PB2194: ISCHEMIC STROKE IN PATIENTS WITH THROMBOCYTOPENIA AFTER ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION
por: Pérez Raya, M., et al.
Publicado: (2022)

PB2302: HEPARIN-INDUCED THROMBOCYTOPENIA ANTIBODIES CAN MAINTAIN PLATELET-ACTIVATING PROPERTIES AFTER TWO SESSIONS OF THERAPEUTIC PLASMA EXCHANGE
por: Gkalea, V., et al.
Publicado: (2022)

PB2300: COMPLEMENT ACTIVATION NEGATIVELY AFFECTS THE PLATELET RESPONSE TO THROMBOPOIETIN RECEPTOR AGONISTS IN PATIENTS WITH IMMUNE THROMBOCYTOPENIA: A PROSPECTIVE COHORT STUDY
por: Åkesson, A., et al.
Publicado: (2022)

PB2338: QUALITY OF LIFE AFTER ALLOGENIC HEMATOPOIETIC STEM CELL TRANSPLANTATION: IMPACT OF CHRONIC GVHD
por: Belloumi, D., et al.
Publicado: (2022)

PB2474: CONSTRUCTION OF NURSING SCHEME FOR PATIENTS UNDERGOING HEMATOPOIETIC STEM CELL TRANSPLANTATION TO PREPARE FOR DISCHARGE
por: Wang, LI, et al.
Publicado: (2023)

PB2573: MICRORNA CLUSTERS FACILITATE THE PREDICTION OF INFECTIOUS FEVER AFTER HEMATOPOIETIC STEM CELL TRANSPLANTATION
por: Liu, LI, et al.
Publicado: (2023)

PB2187: VIABILITY AND PROLIFERATIVE POTENTIAL OF AUTOGRAFT HEMATOPOIETIC STEM CELLS
por: Balashova, V., et al.
Publicado: (2022)

PB2007: FACTORS ASSOCIATED WITH EARLY RELAPSE IN MYELOMA PATIENTS AFTER AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION
por: Karatas, A., et al.
Publicado: (2022)

PB2468: A RETROSPECTIVE STUDY OF ELTROMBOPAG IN PATIENTS WITH THROMBOCYTOPENIA AFTER ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION
por: MA, Liangming, et al.
Publicado: (2023)

PB2418: CLINICAL FEATURES AND PROGNOSIS OF ADENOVIRUS INFECTION AFTER HAPLOIDENTICAL DONOR HEMATOPOIETIC STEM CELL TRANSPLANTATION
por: Sun, Wei, et al.
Publicado: (2023)

PB2694: EFFECT OF NARRATIVE NURSING ON ANXIETY, DEPRESSION AND STIGMA IN PATIENTS AFTER HEMATOPOIETIC STEM CELL TRANSPLANTATION
por: Tang, Jie, et al.
Publicado: (2023)

PB2406: EFFECT OF PINK NOISE ON IMPROVING SLEEP QUALITY OF PATIENTS UNDERGOING HEMATOPOIETIC STEM CELL TRANSPLANTATION
por: Wu, Fangfang, et al.
Publicado: (2023)

PB1839: INDEPENDENT PROGNOSTIC VALUE OF A PLATELET COUNT OVER 300X109/L IN ACUTE MYELOBLASTIC LEUKEMIA PATIENTS TREATED WITH AN INTENSIVE REGIMEN.
por: Ródenas Quiñonero, I., et al.
Publicado: (2022)

PB2174: ON THE ROBUSTNESS OF THE BUCCAL EPITHELIUM FOR ASSESSING RECIPIENT DNA PROFILE IN PATIENTS AFTER HEMATOPOIETIC STEM CELL TRANSPLANTATION
por: Risinskaya, N., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_kr0hn9k10bgrknudjtrpbsb44m